The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The initial report of RTOG 0524: Phase I/II trial of a combination of paclitaxel and trastuzumab with daily irradiation or paclitaxel alone with daily irradiation following transurethral surgery for noncystectomy candidates with muscle-invasive bladder cancer.
M. Dror Michaelson
No relevant relationships to disclose
Chen Hu
No relevant relationships to disclose
Huong T. Pham
No relevant relationships to disclose
Douglas M. Dahl
No relevant relationships to disclose
Chin-Lee Wu
No relevant relationships to disclose
Richard M. Whittington
No relevant relationships to disclose
Gregory P. Swanson
No relevant relationships to disclose
Jacqueline Vuky
No relevant relationships to disclose
R. Jeffrey Lee
No relevant relationships to disclose
Luis Souhami
No relevant relationships to disclose
Brian K. Chang
No relevant relationships to disclose
Asha George
No relevant relationships to disclose
Howard Mark Sandler
No relevant relationships to disclose
William U. Shipley
No relevant relationships to disclose